{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:56:45Z","timestamp":1781647005080,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 diabetes mellitus (T2DM) is a leading cause of death worldwide.To address the rise of T2DM, it might be more effective to create and validate a targeted risk scoring system for specific populations. This study aimed to evaluate and compare the diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) and the Indian Diabetes Risk Score (IDRS) in screening for dysglycemia (i.e. the presence of prediabetes or T2DM) and to identify the factors associated with T2DM risk among young medical students at the Faculty of Medicine, Taiz University, Yemen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cross-sectional study was conducted among 200 medical students without a prior history of diabetes at Taiz University. The FINDRISC and IDRS questionnaires were used along with fasting blood sugar to estimate the efficacy of both risk scores in screening dysglycemia. Descriptive statistics and the chi-square test were used, with\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05 regarded as statistically significant. The diagnostic accuracy of FINDRISC and IDRS was compared using the area under the receiver operating characteristic curve (AUC-ROC). Sensitivity, specificity, and the best cut-off to detect dysglycemia were calculated for each risk score. The best cutoffs were determined by maximizing the Youden Index.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      of the 200 participants, 10.5% and 1.5% were diagnosed with prediabetes and T2DM, respectively, where females had a higher prevalence than males for both outcomes (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). The screening performance for dysglycemia differed significantly between the two tools (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). The FINDRISC achieved a larger AUC-ROC (0.782; 95% CI: 0.68\u20130.88) with\n                      <jats:bold>\u2265<\/jats:bold>\n                      \u20099 as an optimal cut-off (sensitivity: 67.0%, specificity: 80.1%, and Youden index: 0.44) compared to that of IDRS (0.671; 95% CI: 0.56\u20130.78) with\n                      <jats:bold>\u2265<\/jats:bold>\n                      \u200945 as an optimal cut-off (sensitivity: 46.0%, specificity: 80.0%, Youden Index: 0.25). A Bland-Altman plot indicated adequate agreement at lower risk scores; however, significant divergence at higher risk scores, suggesting the tools are not interchangeable.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The FINDRISC demonstrated acceptable diagnostic utility and significantly outperformed the IDRS in this young Yemeni population;with its effectiveness increasing at higher risk scores. This makes it the preferred initial screening tool for identifying individuals with dysglycemia, especially in resource-constrained environments, such as the Yemeni setting. However, due to its modest standalone sensitivity, we recommend that individuals with a FINDRISC score\u2009\u2265\u20099 should undergo definitive laboratory testing to confirm the diagnosis and ensure early detection of dysglycemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13098-026-02123-1","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:55:01Z","timestamp":1775130901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative performance of FINDRISC and IDRS in screening for type 2 diabetes risk among Yemeni university students"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8880-5919","authenticated-orcid":false,"given":"Abdulsalam","family":"Al-Shami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Qasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufeed","family":"Baddah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Kahtan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"1","key":"2123_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jcb.26174","volume":"119","author":"MS Akash","year":"2018","unstructured":"Akash MS, Rehman K, Liaqat A. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2018;119(1):105\u201310. https:\/\/doi.org\/10.1002\/jcb.26174.","journal-title":"J Cell Biochem"},{"key":"2123_CR2","unstructured":"World Health Organization. Diabetes. Geneva: World Health Organization. 2021. Available from: [accessed on 2021 Jun 08]."},{"issue":"3","key":"2123_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.beem.2016.05.003","volume":"30","author":"LM Jaacks","year":"2016","unstructured":"Jaacks LM, Siegel KR, Gujral UP, Narayan KV. Type 2 diabetes: A 21st century epidemic. Best Pract Res Clin Endocrinol Metab. 2016;30(3):331\u201343. https:\/\/doi.org\/10.1016\/j.beem.2016.05.003.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2123_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119"},{"issue":"2","key":"2123_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.diabres.2013.11.001","volume":"103","author":"J Beagley","year":"2014","unstructured":"Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract. 2014;103(2):150\u201360. https:\/\/doi.org\/10.1016\/j.diabres.2013.11.001.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2123_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.diabres.2004.02.001","volume":"65","author":"M Al-Habori","year":"2004","unstructured":"Al-Habori M, Al-Mamari M, Al-Meeri A. Type II diabetes mellitus and impaired glucose tolerance in yemen: prevalence, associated metabolic changes and risk factors. Diabetes Res Clin Pract. 2004;65(3):275\u201381. https:\/\/doi.org\/10.1016\/j.diabres.2004.02.001.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2123_CR7","first-page":"42","volume":"14","author":"AA Gunaid","year":"2008","unstructured":"Gunaid AA, Assabri AM. Prevalence of type 2 diabetes and other cardiovascular risk factors in a semirural area in Yemen. East Mediterr Health J. 2008;14(1):42\u201356.","journal-title":"East Mediterr Health J"},{"issue":"1","key":"2123_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-021-05585-2","volume":"65","author":"MK Ali","year":"2022","unstructured":"Ali MK, Pearson-Stuttard J, Selvin E, Gregg EW. Interpreting global trends in type 2 diabetes complications and mortality. Diabetologia. 2022;65(1):3\u201313. https:\/\/doi.org\/10.1007\/s00125-021-05585-2.","journal-title":"Diabetologia"},{"issue":"4","key":"2123_CR9","first-page":"291","volume":"47","author":"AH Ziyab","year":"2015","unstructured":"Ziyab AH, Mohammad A, Maclean E, Behbehani K, Carballo M. Diabetes: a fast evolving epidemic. Kuwait Med J. 2015;47(4):291\u2013URL301. http:\/\/www.kma.org.kw\/uploads\/versions\/OBNMZHFMDVCUTNOYYKOYAXBV.pdf.","journal-title":"Kuwait Med J"},{"issue":"3","key":"2123_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2337\/diacare.26.3.725","volume":"26","author":"J Lindstrom","year":"2003","unstructured":"Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26(3):725\u201331. https:\/\/doi.org\/10.2337\/diacare.26.3.725.","journal-title":"Diabetes Care"},{"issue":"13","key":"2123_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078950","volume":"8","author":"CM Phillips","year":"2013","unstructured":"Phillips CM, Kearney PM, McCarthy VJ, Harrington JM, Fitzgerald AP, Perry IJ. Comparison of diabetes risk score estimates and cardiometabolic risk profiles in a middle-aged Irish population. PLoS One. 2013;8(13):e78950. https:\/\/doi.org\/10.1371\/journal.pone.0078950.","journal-title":"PLoS One"},{"key":"2123_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12963-018-0166-4","volume":"16","author":"J Lin","year":"2018","unstructured":"Lin J, Thompson TJ, Cheng YJ, Zhuo X, Zhang P, Gregg E, et al. Projection of the future diabetes burden in the United States through 2060. Popul Health Metr. 2018;16:1\u20139. https:\/\/doi.org\/10.1186\/s12963-018-0166-4.","journal-title":"Popul Health Metr"},{"key":"2123_CR13","volume-title":"Medical management of type 2 diabetes","year":"2020","unstructured":"Meneghini LF, editor. Medical management of type 2 diabetes. 8th ed. Alexandria: American Diabetes Association; 2020.","edition":"8"},{"key":"2123_CR14","unstructured":"World Health Organization. Screening for type 2 diabetes: report of a World Health Organization and International Diabetes Federation meeting. Geneva, 2003. (Available from: http:\/\/www.who.int\/iris\/handle\/10665\/68614) [4 August 2007]."},{"issue":"5","key":"2123_CR15","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.dsx.2020.07.025","volume":"14","author":"D Kumar","year":"2020","unstructured":"Kumar D, Prakash B, Subhash CBJ, Kadkol PS, Arun V, Thomas JJ. An android smartphone-based randomized intervention improves the quality of life in patients with type 2 diabetes in Mysore, Karnataka, India. Diabetes Metab Syndr. 2020;14(5):1327\u201332. https:\/\/doi.org\/10.1016\/j.dsx.2020.07.025.","journal-title":"Diabetes Metab Syndr"},{"key":"2123_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d7163","volume":"343","author":"D Noble","year":"2011","unstructured":"Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. BMJ. 2011;343:d7163. https:\/\/doi.org\/10.1136\/bmj.d7163.","journal-title":"BMJ"},{"key":"2123_CR17","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/aje\/kwq030","volume":"171","author":"DM Mann","year":"2010","unstructured":"Mann DM, Bertoni AG, Shimbo D, Carnethon MR, Chen H, Jenny NS, et al. Comparative validity of 3 diabetes mellitus risk prediction scoring models in a multiethnic US cohort: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2010;171:980\u20138. https:\/\/doi.org\/10.1093\/aje\/kwq030.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"2123_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1463-1326.2006.00612.x","volume":"9","author":"V Mohan","year":"2007","unstructured":"Mohan V, Sandeep S, Deepa M, Gokulakrishnan K, Datta M, Deepa R. A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai urban rural epidemiology study (CURES-38). Diabetes Obes Metab. 2007;9(3):337\u201343. https:\/\/doi.org\/10.1111\/j.1463-1326.2006.00612.x.","journal-title":"Diabetes Obes Metab"},{"key":"2123_CR19","unstructured":"Saleem SM, Raina AF, Khan SM, Jan SS. Indian diabetic risk score-A tool for predicting risk of undiagnosed type 2 diabetes mellitus. Int J Curr Res Rev. 2017;9:39\u201342. Available from:https:\/\/ijcrr.com\/uploads\/96_pdf.pdf"},{"key":"2123_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-018-0310-0","volume":"10","author":"AS Meijnikman","year":"2018","unstructured":"Meijnikman AS, De Block CE, Verrijken A, Mertens I, Van Gaal LF. Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome. Diabetol Metab Syndr. 2018;10:1\u20136. https:\/\/doi.org\/10.1186\/s13098-018-0310-0.","journal-title":"Diabetol Metab Syndr"},{"issue":"6","key":"2123_CR21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.pcd.2018.07.015","volume":"12","author":"A Bernabe-Ortiz","year":"2018","unstructured":"Bernabe-Ortiz A, Perel P, Miranda JJ, Smeeth L. Diagnostic accuracy of the Finnish diabetes risk score (FINDRISC) for undiagnosed T2DM in Peruvian population. Prim Care Diabetes. 2018;12(6):517\u201325. https:\/\/doi.org\/10.1016\/j.pcd.2018.07.015.","journal-title":"Prim Care Diabetes"},{"issue":"1","key":"2123_CR22","doi-asserted-by":"publisher","first-page":"8290710","DOI":"10.1155\/2017\/8290710","volume":"2017","author":"AE Al-Shudifat","year":"2017","unstructured":"Al-Shudifat AE, Al-Shdaifat A, Al-Abdouh AA, Aburoman MI, Otoum SM, Sweedan AG, et al. Diabetes risk score in a young student population in jordan: a cross-sectional study. J Diabetes Res. 2017;2017(1):8290710. https:\/\/doi.org\/10.1155\/2017\/8290710.","journal-title":"J Diabetes Res"},{"key":"2123_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/2050312113508390","author":"MS D\u2019Souza","year":"2013","unstructured":"D\u2019Souza MS, Amirtharaj A, Venkatesaperumal R, Isac C, Maroof S. Risk-assessment score for screening diabetes mellitus among Omani adults. SAGE Open Med. 2013. https:\/\/doi.org\/10.1177\/2050312113508390.","journal-title":"SAGE Open Med"},{"issue":"30","key":"2123_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-020-00590-8","volume":"12","author":"M Abdallah","year":"2020","unstructured":"Abdallah M, Sharbaji S, Sharbaji M, Daher Z, Faour T, Mansour Z, et al. Diagnostic accuracy of the Finnish Diabetes Risk Score for the prediction of undiagnosed type 2 diabetes, prediabetes, and metabolic syndrome in the Lebanese University. Diabetol Metab Syndr. 2020;12(30):84. https:\/\/doi.org\/10.1186\/s13098-020-00590-8.","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"2123_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.2337\/diacare.18.3.382","volume":"18","author":"WH Herman","year":"1995","unstructured":"Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE. A new and simple questionnaire to identify people at increased risk for undiag\u00acnosed diabetes. Diabetes Care. 1995;18(3):382\u20137. https:\/\/doi.org\/10.2337\/diacare.18.3.382.","journal-title":"Diabetes Care"},{"key":"2123_CR26","unstructured":"Smith Liz. New AHA recommendations for blood pressure measurement: American Heart Association Practice Guide\u00aclines. Am Fam Physician 2005; 72(7): 1391\u20138. Available from: https:\/\/www.aafp.org\/afp\/2005\/1001\/p1391.html"},{"issue":"1","key":"2123_CR27","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc17-S005","volume":"40","author":"American Diabetes Association","year":"2017","unstructured":"American Diabetes Association. 2. classification and diagnosis of diabetes. Diabetes Care. 2017;40(1):S11\u201324. https:\/\/doi.org\/10.2337\/dc17-S005.","journal-title":"Diabetes Care"},{"issue":"8","key":"2123_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71908-9","volume":"10","author":"X Lin","year":"2020","unstructured":"Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10(8):14790. https:\/\/doi.org\/10.1038\/s41598-020-71908-9.","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"2123_CR29","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.2337\/dc23-S001","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 1. Improving care and promoting health in populations: standards of care in diabetes\u20142023. Diabetes Care. 2023;46(Suppl 1):S10\u20138. https:\/\/doi.org\/10.2337\/dc23-S001.","journal-title":"Diabetes Care"},{"key":"2123_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.22270\/ujpr.v5i4.438","volume":"5","author":"OA Osman","year":"2020","unstructured":"Osman OA, Saeed AA, Mousnad MA, Hamid A. Assessment of the risk of type 2 diabetes among healthy without diabetes in Sudan using the FINDRISC tool. Univers J Pharm Res. 2020;5:37\u201341. https:\/\/doi.org\/10.22270\/ujpr.v5i4.438.","journal-title":"Univers J Pharm Res"},{"issue":"1","key":"2123_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/epirev\/mxq019","volume":"33","author":"B Buijsse","year":"2011","unstructured":"Buijsse B, Simmons RK, Griffin SJ, Schulze MB. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev. 2011;33(1):46\u201362. https:\/\/doi.org\/10.1093\/epirev\/mxq019.","journal-title":"Epidemiol Rev"},{"key":"2123_CR32","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/jdi.12344","volume":"6","author":"B Bhowmik","year":"2015","unstructured":"Bhowmik B, Akhter A, Ali L, Ahmed T, Pathan F, Mahtab H, et al. Simple risk score to detect rural Asian Indian (Bangladeshi) adults at high risk for type 2 diabetes. J Diabetes Investig. 2015;6:670\u20137. https:\/\/doi.org\/10.1111\/jdi.12344.","journal-title":"J Diabetes Investig"},{"key":"2123_CR33","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp15X687661","author":"BJ Gray","year":"2015","unstructured":"Gray BJ, Bracken RM, Turner D, Morgan K, Williams M, Rice S, et al. Different type 2 diabetes risk assessments predict dissimilar numbers at \u2018high risk\u2019: a retrospective analysis of diabetes risk-assessment tools. Br J Gen Pract. 2015. https:\/\/doi.org\/10.3399\/bjgp15X687661.","journal-title":"Br J Gen Pract"},{"issue":"2","key":"2123_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pcd.2012.01.003","volume":"6","author":"K Viitasalo","year":"2012","unstructured":"Viitasalo K, Lindstr\u00f6m J, Hemi\u00f6 K, Puttonen S, Koho A, H\u00e4rm\u00e4 M, et al. Occupational health care identifies risk for type 2 diabetes and cardiovascular disease. Prim Care Diabetes. 2012;6(2):95\u2013102. https:\/\/doi.org\/10.1016\/j.pcd.2012.01.003.","journal-title":"Prim Care Diabetes"},{"key":"2123_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/DHPS.S258331","volume":"12","author":"M Sapkota","year":"2020","unstructured":"Sapkota M, Timilsina A, Shakya M, Thapa TB, Shrestha S, Pokhrel S, et al. Metabolic syndrome and diabetes risk among young adult students in the health sciences from Kathmandu, Nepal. Drug Healthc Patient Saf. 2020;12:125\u201333. https:\/\/doi.org\/10.2147\/DHPS.S258331.","journal-title":"Drug Healthc Patient Saf"},{"issue":"14","key":"2123_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.21608\/ZUMJ.2023.231878.2863","volume":"30","author":"MH Al-Dolae","year":"2024","unstructured":"Al-Dolae MH, Salah MG, Al-Najjar AM, Al-Rassas SH, Al-Madwami MA, Al-khadher MA. Assessment of diabetes risk among the fifth and sixth years medical students in Thamar University, Yemen, a cross-sectional study. Zagazig Univ Med J. 2024;30(14):385\u201394. https:\/\/doi.org\/10.21608\/ZUMJ.2023.231878.2863.","journal-title":"Zagazig Univ Med J"},{"issue":"1","key":"2123_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46943-x","volume":"13","author":"N Ali","year":"2023","unstructured":"Ali N, Samadder M, Shourove JH, Taher A, Islam F. Prevalence and factors associated with metabolic syndrome in university students and academic staff in Bangladesh. Sci Rep. 2023;13(1):19912. https:\/\/doi.org\/10.1038\/s41598-023-46943-x.","journal-title":"Sci Rep"},{"issue":"1","key":"2123_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s42269-020-00440-7","volume":"44","author":"AC Nnamudi","year":"2020","unstructured":"Nnamudi AC, Orhue NE, Ijeh II. Assessment of the FINDRISC tool in predicting the risk of developing type 2 diabetes mellitus in a young adult Nigerian population. Bull Natl Res Cent. 2020;44(1):186. https:\/\/doi.org\/10.1186\/s42269-020-00440-7.","journal-title":"Bull Natl Res Cent"},{"issue":"1","key":"2123_CR39","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1186\/s12889-023-15819-0","volume":"23","author":"HF Farag","year":"2023","unstructured":"Farag HF, Elrewany E, Abdel-Aziz BF, Sultan EA. Prevalence and predictors of undiagnosed type 2 diabetes and pre-diabetes among adult Egyptians: a community-based survey. BMC Public Health. 2023;23(1):949. https:\/\/doi.org\/10.1186\/s12889-023-15819-0.","journal-title":"BMC Public Health"},{"issue":"7","key":"2123_CR40","doi-asserted-by":"publisher","first-page":"e0003087","DOI":"10.1371\/journal.pgph.0003087","volume":"5","author":"T Ahmad","year":"2025","unstructured":"Ahmad T, Tauqir A, Tariq H, Qureshi A, Jalaluddin S, Khan I. Sex differences in risk of developing type 2 diabetes mellitus (T2DM): A feasibility assessment of FINDRISC scoring and barriers to disease management in a low-income settlement of Rawalpindi, Pakistan. PLOS Global Public Health. 2025;5(7):e0003087. https:\/\/doi.org\/10.1371\/journal.pgph.0003087.","journal-title":"PLOS Global Public Health"},{"issue":"1","key":"2123_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.52976\/vansaglik.1162785","volume":"16","author":"H Evcimen","year":"2023","unstructured":"Evcimen H, Ayy\u0131ld\u0131z N\u0130, Do\u011fan U. Diabetes risk score of adult applications to primary health care center: a cross-sectional study. Van Sa\u011fl\u0131k Bilimleri Dergisi. 2023;16(1):53\u20139. https:\/\/doi.org\/10.52976\/vansaglik.1162785.","journal-title":"Van Sa\u011fl\u0131k Bilimleri Dergisi"},{"issue":"44","key":"2123_CR42","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027721","volume":"100","author":"\u00d6 Sezer","year":"2021","unstructured":"Sezer \u00d6, Laf\u00e7i N\u00d6, Korkmaz S, Da\u011fdeviren HN. Prediction of a 10-year risk of type 2 diabetes mellitus in the Turkish population: a cross-sectional study. Medicine. 2021;100(44):e27721. https:\/\/doi.org\/10.1097\/MD.0000000000027721.","journal-title":"Medicine"},{"issue":"2","key":"2123_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.dsx.2009.04.006","volume":"3","author":"N Zahid","year":"2009","unstructured":"Zahid N, Shi Z, Claussen B, Hussain A. Prevalence and risk factors for diabetes, comparison of rural populations in Bangladesh, China and Pakistan. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2009;3(2):109\u201312. https:\/\/doi.org\/10.1016\/j.dsx.2009.04.006.","journal-title":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews"},{"key":"2123_CR44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4103\/2319-4170.143508","volume":"38","author":"A Bhadoria","year":"2015","unstructured":"Bhadoria A, Kasar P, Toppo N. Validation of Indian diabetic risk score in diagnosing type 2 diabetes mellitus against high fasting blood sugar levels among adult population of central India. Biomed J. 2015;38:359\u201360. https:\/\/doi.org\/10.4103\/2319-4170.143508.","journal-title":"Biomed J"},{"issue":"1","key":"2123_CR45","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4103\/2249-4863.214957","volume":"6","author":"SD Pawar","year":"2017","unstructured":"Pawar SD, Naik JD, Prabhu P, Jatti GM, Jadhav SB, Radhe BK. Comparative evaluation of Indian diabetes risk score and Finnish diabetes risk score for predicting risk of diabetes mellitus type II: a teaching hospital-based survey in Maharashtra. J Fam Med Prim Care. 2017;6(1):120\u20135. https:\/\/doi.org\/10.4103\/2249-4863.214957.","journal-title":"J Fam Med Prim Care"},{"issue":"3","key":"2123_CR46","doi-asserted-by":"publisher","first-page":"587","DOI":"10.13075\/ijomeh.1896.00407","volume":"28","author":"GJ Vandersmissen","year":"2015","unstructured":"Vandersmissen GJ, Godderis L. Evaluation of the Finnish diabetes risk score (FINDRISC) for diabetes screening in occupational health care. Int J Occup Med Environ Health. 2015;28(3):587\u201391. https:\/\/doi.org\/10.13075\/ijomeh.1896.00407.","journal-title":"Int J Occup Med Environ Health"},{"issue":"8","key":"2123_CR47","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2337\/dc11-0206","volume":"34","author":"R Schmid","year":"2011","unstructured":"Schmid R, Vollenweider P, Waeber G, Marques-Vidal P. Estimating the risk of developing type 2 diabetes: a comparison of several risk scores: the cohorte Lausannoise study. Diabetes Care. 2011;34(8):1863\u20138. https:\/\/doi.org\/10.2337\/dc11-0206.","journal-title":"Diabetes Care"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02123-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02123-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02123-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:24:53Z","timestamp":1781645093000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02123-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2123"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02123-1","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.diabres.2021.109119","asserted-by":"subject"}],"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7781850\/v1","asserted-by":"object"}]},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was carried out in accordance with the Declaration of Helsinki for studies on human subjects. The Ethical approval for the study was obtained from the Research Ethics Committee of the Faculty of Medicine and Health Sciences, Taiz University, Taiz, Yemen. Written informed consent was taken from every participant after a full illustration of the purpose of the study. Each participant was interviewed and completed a standardized questionnaire that included family history, habits, diets, uses of drugs and history of disease like diabetes, hypertension and cardiac diseases. They were told that all the data will be confidential and will be used only for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}